While it has been clear from early on in the COVID-19 pandemic that some severe cases are characterised by a hyperinflammatory state, targeting the cytokines involved in that inflammation has proven to be remarkably complicated. Now, new research shows that inhibition of IL-1, but not of IL-6, is associated with a reduction in mortality in ...
Is targeting one cytokine better than another in treating COVID-19?
By Dave Levitan
10 Feb 2021